Thursday, Oct 28, 2021 | Last Update : 04:14 PM IST

Bharat Biotech Vaccine

Bharat Biotech awaits feedback from WHO for Covaxin EUL

Rolling data allows the WHO to start its review right away, as information continues to come in, to accelerate the overall review process

17 Sep 2021 2:31 PM

Transparency needed to remove all vaccine fears

Frankly, it’s not just bizarre but deplorable to frame differences over the efficacy of Covaxin as issues of national pride

22 Jan 2021 6:36 AM

Joint push by Serum Institute, Bharat Biotech to assure people on vaccine efficacy

The chiefs of both firms asserted their intent to jointly develop, manufacture and supply Covid vaccines in India and other nations too

06 Jan 2021 10:31 AM

Covishield to cost Rs.200 per dose, export banned by government

The government is now in a hurry to start vaccination drive, the schedule for which will be announced soon

05 Jan 2021 7:23 AM

Bharat Biotech recruits 23k volunteers for COVID-19 vaccine trials

Covaxin has been evaluated in approximately 1,000 subjects in Phase I and Phase II clinical trials

03 Jan 2021 11:50 AM

ADVERTISEMENT

Bharat Biotech sends Phase-2 study results of Covaxin trial

Altogether, the data of human trials on 26,000 volunteers has to be submitted by the company to the subject committee

24 Dec 2020 4:39 AM

ADVERTISEMENT
ADVERTISEMENT